• Silvana F Marasco, Michael Bailey, Daniel McGlade, Greg Snell, Glen Westall, Takahiro Oto, and David Pilcher.
• Cardiothoracic Surgery Unit, The Alfred Hospital, Prahran, Melbourne, Australia. s.marasco@alfred.org.au
• J. Heart Lung Transplant. 2011 Apr 1; 30 (4): 414-9.

BackgroundThe aim of this retrospective study was to determine whether the type of preservation solution significantly alters outcomes in lung transplantation, with particular emphasis on primary graft dysfunction and mortality.MethodsData on 310 consecutive lung transplant patients, which were prospectively collected, were analyzed. The main outcome variables were all-cause mortality and primary graft dysfunction. Patients were grouped according to donor organ preservation solution, either Euro-Collins, Papworth solution or Perfadex. Multivariate analysis with an additional sensitivity analysis utilizing a propensity score for the use of Papworth solution was performed.ResultsPapworth solution was associated with significantly increased mortality compared with the other preservation solutions [odds ratio (OR) = 2.36 (1.21 to 4.58), p = 0.01]. Perfadex was associated with a reduced incidence of primary graft dysfunction at 48 hours (OR = 0.23 [0.08 to 0.68], p = 0.008). Increasing donor age was also associated with increased risk of death (OR = 1.03 [1.01 to 1.04], p = 0.004).ConclusionPapworth solution for donor lung preservation is associated with an increased mortality in lung transplant recipients.Crown Copyright © 2011. Published by Elsevier Inc. All rights reserved.

11 keywords...

hide…